Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • CDK
    (848)
  • Apoptosis
    (192)
  • GSK-3
    (63)
  • PROTACs
    (47)
  • Akt
    (27)
  • Autophagy
    (25)
  • Bcl-2 Family
    (24)
  • FLT
    (21)
  • VEGFR
    (20)
  • Others
    (284)
Filter
Search Result
Results for "

CDK

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    939
    TargetMol | Inhibitors_Agonists
  • Compound Libraries
    4
    TargetMol | Compound_Libraries
  • Peptide Products
    19
    TargetMol | Peptide_Products
  • Dye Reagents
    1
    TargetMol | Dye_Reagents
  • PROTAC Products
    76
    TargetMol | PROTAC
  • Natural Products
    56
    TargetMol | Natural_Products
  • Recombinant Protein
    34
    TargetMol | Recombinant_Protein
  • Isotope Products
    4
    TargetMol | Isotope_Products
  • Antibody Products
    117
    TargetMol | Antibody_Products
  • Cell Research
    4
    TargetMol | Disease_Modeling_Products
  • Reference Standards
    2
    TargetMol | Disease_Modeling_Products
  • 2
    TargetMol | Inhibitors_Agonists
CDK8-IN-1
T107401629633-48-2In house
CDK8-IN-1 is a selective CDK8 inhibitor (IC50: 3 nM).
  • $89
In Stock
Size
QTY
CDK9-IN-10
T107423542-63-0In house
CDK9-IN-10 is a potent inhibitor of CDK9 and serves as the ligand for the PROTAC CDK9 degrader-2.
  • $30
In Stock
Size
QTY
CDK9-IN-7
T107452369981-71-3In house
CDK9-IN-7 is a highly selective and orally active CDK9/cyclin T inhibitor (IC50: 11 nM), which exhibits more potent over other CDKs (CDK4/cyclinD: 148 nM; CDK6/cyclinD: 145 nM).
  • $83
In Stock
Size
QTY
TargetMol | Inhibitor Sale
CDK9-IN-8
T107462105956-51-0In house
CDK9-IN-8 is a highly potent and selective CDK9 inhibitor (IC50: 12 nM).
  • $32
In Stock
Size
QTY
Cdk1/2 Inhibitor III
T14914443798-55-8In house
Cdk1/2 Inhibitor III is a selective inhibitor of Cdk1/2 with an IC50 value of 2.1 μM against CDK1/cyclin B.
  • $123
In Stock
Size
QTY
CDK9-IN-2
T149181263369-28-3In house
CDK9-IN-2 is a specific CDK9 inhibitor with an IC50 of 5 nM in the A2058 skin cell line (72 hours) and 7 nM in the H929 multiple myeloma cell line (72 hours).
  • $80
In Stock
Size
QTY
CDK12-IN-3
T149902220184-50-7In house
CDK12-IN-3 is a selective and potent CDK12 inhibitor with anti-tumor activity, which can be used to study malignant tumors.
  • $132
In Stock
Size
QTY
CDK4-IN-1
T20821256963-02-6In house
CDK4 inhibitor is a novel and specific CDK4/Cyclin D1 inhibitor with an IC50 of 10 nM; 1500 and 500 fold than CDK1/Cyclin B (IC50>15 uM) and CDK2/Cyclin A (IC50=5.265 uM) respectively.
  • $2,120
10-14 weeks
Size
QTY
CDK-IN-10
T60869660822-84-4
CDK-IN-10 is a cell cycle protein-dependent kinase (CDK) inhibitor with potential anticancer activity for cancer research.
  • $82
In Stock
Size
QTY
TargetMol | Inhibitor Sale
CDK4/6-IN-2
T107361800506-48-2
CDK4/6-IN-2 is a potent inhibitor of CDK4 and CDK6 [IC50s: 2.7 and 16 nM].
  • $97
In Stock
Size
QTY
CDK4/6-IN-3
T107372366237-37-6
CDK4/6-IN-3, a brain-penetrant CDK4/CDK6 inhibitor (Kis: <0.3 nM and 2.2 nM), is used for the treatment of glioblastoma and inhibits CDK1 with a Ki of 110 nM.
  • $4,020
3-6 months
Size
QTY
CDK8/19-IN-1
T107391818427-07-4
CDK8/19-IN-1 is a selective, orally bioavailable dual inhibitor of CDK8 and CDK19, with IC50 values of 0.46 nM for CDK8, 0.99 nM for CDK19, and 270 nM for [CDK9].
  • $1,670
6-8 weeks
Size
QTY
CDK9-IN-1
T107411415559-43-1
CDK9-IN-1 is a selective and potent CDK9 inhibitor with antiviral activity used in the study of PRRSV infections.
  • $35
In Stock
Size
QTY
CDK9-IN-11
T107432748368-15-0
CDK9-IN-11 is a potent CDK9 inhibitor and serves as the ligand for the PROTAC CDK9 Degrader-1 [1].
  • $1,520
10-14 weeks
Size
QTY
CDK9-IN-9
T107472246956-84-1
CDK9-IN-9 is a potent and selective CDK9 inhibitor (IC50: 1.8 nM) with anti-cancer activity. It inhibits CDK2 (IC50: 155 nM).
  • $1,978
8-10 weeks
Size
QTY
PROTAC CDK2/9 Degrader-1
T125522408641-24-5
PROTAC CDK2/9 Degrader-1 is a potent CDK2 and CDK9 dual degrader(DC50 of 62 nM and 33 nM).
  • Inquiry Price
Inquiry
Size
QTY
CDK12-IN-E9
T149152020052-55-3
CDK12-IN-E9 is a cell cycle protein kinase (CDK) inhibitor with anticancer and antitumor activity that can be used in the study of breast cancer.
  • $132
In Stock
Size
QTY
CDK2-IN-4
T149162079895-42-2
CDK2-IN-4 is a potent and selective inhibitor of CDK2 with an IC50 of 44 nM for CDK2/cyclin A. It shows 2,000-fold selectivity over CDK1/cyclin B with IC50 of 86 uM.
  • $79
In Stock
Size
QTY
CDK8-IN-3
T149171884500-15-5
CDK8-IN-3 [CDK8-IN-3] is a potent and selective inhibitor of CDK8.
  • $1,110
8-10 weeks
Size
QTY
CDK8-IN-4
T173051613638-82-6
CDK8-IN-4, an inhibitor of CDK8, has an IC50 value of 0.2 nM.
  • $747
6-8 weeks
Size
QTY
PROTAC CDK9 degrader-2
T177282435721-30-3
PROTAC CDK9 degrader-2 (compounds 11c) is a potent and selective CDK9 degrader based on PROTAC, with an IC50 of 17 μM in MCF-7 cell lines. Natural product Wogonin binds ubiquitin E3 ligase cereblon (CRBN) via a linker to form PROTAC[1].
  • Inquiry Price
Inquiry
Size
QTY
GSK-3/CDK5/CDK2-IN-1
GSK-3/CDK5/CDK2-IN-1
T35555395074-72-3
GSK-3/CDK5/CDK2-IN-1 is an imidazole derivative compound that inhibits cdk5, cdk2, and GSK-3.it has demonstrated applications in cancer research and the study of neurodegenerative diseases [1].
    Inquiry
    CDK-IN-6
    T36741779353-02-5
    CDK-IN-6, a pyrazolo[1,5-a]pyrimidine compound, exhibits potent anticancer activities as a CDK inhibitor[1].
      Inquiry
      CDK7/9 tide
      T36743
      CDK7/9 tide is a peptide substrate for CDK7 or CDK9[1].
      • $166
      Inquiry
      Size
      QTY